IBM is teaming up with the World Health Organization, the Centers for Disease Control and Prevention, and other organisations to make some of its software open-source. The idea is to fight more effectively the spread of infectious diseases, including the H5N1 influenza:
With growing concerns over potential outbreaks of new strains of disease, and their ability to spread more easily because of modern transportation, IBM scientists have formed a steering committee with worldwide health organizations and universities to guide efforts to address the issue. Together, they will explore the use of advanced analytical and computer technology as part of a global preparedness program for responding to potential infectious disease outbreaks around the world…
Among the technologies that will be used is a software framework IBM developed to allow electronic health information to be more easily shared and mined for trends, such as the outbreak of disease. Called the Interoperable Healthcare Information Infrastructure (IHII), the technology is designed to improve communication and collaboration among medical professionals and researchers by helping them collect and share health data. IBM will expand the role of IHII to include public health issues, responding to global calls for pandemic preparedness by facilitating the sharing of clinical data among medical facilities, laboratories and public health agencies.
IBM also plans to build a community of users around its epidemiological modeling framework, called Spatio-Temporal Epidemiological Modeller (STEM), which can tap the information collected from IHII, along with additional information such as roadmaps, airport locations, travel patterns, and bird migration routes around the world. It will allow users to rapidly develop models for how a disease is likely to geographically spread over time. These models can help public health experts and governmental planners develop more effective preparedness plans.
Ultimately, those plans could include development and distribution of more effective and timely vaccines as IBM taps into knowledge gained through a planned collaborative initiative known as “Project Checkmate,” in which IBM and The Scripps Research Institute propose to conduct advanced biological research on influenza viruses. The collaboration is designed to predict the way viruses will mutate over time using advanced predictive techniques running on high performance computing systems, such as IBM’s BlueGene supercomputer, allowing effective vaccines to be developed by drug-makers, drawing on the immunology and chemistry expertise at Scripps.
IBM scientists at the company’s Research Labs in China, India, Israel, Japan, Switzerland and the U.S. will serve as focal points for the collaboration.